251 related articles for article (PubMed ID: 23669295)
41. Association between the Rs3087243 polymorphism and risk for diabetes: a meta-analysis.
Liu J; Zhang HX
Genet Mol Res; 2013 Dec; 12(4):6344-50. PubMed ID: 24390983
[TBL] [Abstract][Full Text] [Related]
42. [Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China].
Gao Q; Zhang S; Wu L; Jia M; Mi Y; Liu D
Wei Sheng Yan Jiu; 2011 Nov; 40(6):709-13. PubMed ID: 22279662
[TBL] [Abstract][Full Text] [Related]
43. Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil.
Gusatti Cde S; Costi C; de Medeiros RM; Halon ML; Grandi T; Medeiros AF; da Silva CM; Rodenbusch R; Silva MS; Niel C; Rossetti ML
J Med Virol; 2016 Oct; 88(10):1759-66. PubMed ID: 26959287
[TBL] [Abstract][Full Text] [Related]
44. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
45. Updated analysis of studies on the cytotoxic T-lymphocyte-associated antigen-4 gene A49G polymorphism and Hashimoto's thyroiditis risk.
Ji R; Feng Y; Zhan WW
Genet Mol Res; 2013 Apr; 12(2):1421-30. PubMed ID: 23661465
[TBL] [Abstract][Full Text] [Related]
46. Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection.
Zhang P; Li F; Li N; Zhu Q; Yang C; Han Q; Chen J; Lv Y; Yu L; Wei P; Liu Z
Hum Immunol; 2014 Aug; 75(8):709-14. PubMed ID: 24768946
[TBL] [Abstract][Full Text] [Related]
47. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
Zhang PA; Wu JM; Li Y; Yang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
[TBL] [Abstract][Full Text] [Related]
48. [Relationship between genetic polymorphisms of Interferon-gamma gene intron 1 +874 site and susceptibility of hepatitis B virus infection].
Zhang PA; Wu JM; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):41-3. PubMed ID: 16737571
[TBL] [Abstract][Full Text] [Related]
49. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection.
Kim YJ; Lee HS; Yoon JH; Kim CY; Park MH; Kim LH; Park BL; Shin HD
Hum Mol Genet; 2003 Oct; 12(19):2541-6. PubMed ID: 12915457
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani A; Al-Ahdal M; Abdo A; Sanai F; Al-Anazi M; Khalaf N; Viswan NA; Al-Ashgar H; Al-Humaidan H; Al-Suwayeh R; Hussain Z; Alarifi S; Al-Okail M; Almajhdi FN
J Med Virol; 2012 Sep; 84(9):1353-9. PubMed ID: 22825813
[TBL] [Abstract][Full Text] [Related]
51. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947
[TBL] [Abstract][Full Text] [Related]
52. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
53. Correlations of CTLA-4 gene polymorphisms and hepatitis C chronic infection.
Danilovic DL; Mendes-Correa MC; Lima EU; Zambrini H; K Barros R; Marui S
Liver Int; 2012 May; 32(5):803-8. PubMed ID: 22136395
[TBL] [Abstract][Full Text] [Related]
54. Association of cytotoxic T-lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation.
Yang CH; Chen XX; Chen L; Zheng DH; Liu QS; Xie WF
Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28333403
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
56. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis.
Chen Z; Fei M; Fu D; Zhang L; Ma Y; Wang Y; Zhang F; Xia Q; Wang X
Gene; 2013 Mar; 516(2):263-70. PubMed ID: 23261825
[TBL] [Abstract][Full Text] [Related]
57. Association between cytotoxic T-lymphocyte-associated antigen 4 +49A/G polymorphism and persistent hepatitis B virus infection in the Asian population: evidence from the current studies.
Huang R; Hao Y; Fan Y; Yang C; Wu K; Cao S; Wu C
Genet Test Mol Biomarkers; 2013 Aug; 17(8):601-6. PubMed ID: 23725008
[TBL] [Abstract][Full Text] [Related]
58. Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk.
Zhang Y; Zhang S; Xia W; Dong Z
J Cancer Res Ther; 2018 Jun; 14(Supplement):S526-S532. PubMed ID: 29970719
[TBL] [Abstract][Full Text] [Related]
59. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China.
Li X; Liu W; Wang H; Jin X; Fang S; Shi Y; Liu Z; Zhang S; Yang S
Virus Res; 2012 Jan; 163(1):328-33. PubMed ID: 22056847
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Forkhead Box P3 gene polymorphisms in chronic HBV infection.
Akgöllü E
J Gene Med; 2020 Jun; 22(6):e3172. PubMed ID: 32037623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
